Drug
Roxadustat clinical trials
Also written FG-4592 and ASP1517.
- studies test it
- 61
- open now
- 6
- in phase 3
- 26
- first study started
- 2006
Keep track of what changes. Save the roxadustat studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
60 studies that test it; most in 2016 (8); 1 more planned to start later
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 8 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 13
- Phase 2
- 15
- Phase 3
- 26
- Phase 4
- 8
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 46 · Other 15
FibroGen (20) · Astellas Pharma Inc (13) · Astellas Pharma Europe B.V. (7) · AstraZeneca (3) · Astellas Pharma Global Development, Inc. (2) · Peking Union Medical College Hospital (2) · Mansoura University (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Often tested with
Tested in the same studies.
Darbepoetin alfa (2) · Lanthanum carbonate (1) · Lanthanum (1) · AST 120 (1) · Charcoal (1) · Warfarin (1) · Sacubitril valsartan (1)
Studies
Open first, then newest update. How each study uses roxadustat is read from its arms, and is right about nine times in ten.
Testing it · 61
- A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)Not yet recruitingPhase 3Kyntra BioNCT07722988Written as Roxadustat
- Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis PatientsNot yet recruitingPhase 4Tianjin Medical University General HospitalNCT07162090Written as Roxadustat
- Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis PatientsRecruitingPhase 1/2Mansoura UniversityNCT06903559Written as Roxadustat
- Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis PatientsRecruitingPhase 1/2Mansoura UniversityNCT06917950Written as Roxadustat
- The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyNot yet recruitingPhase 2Region StockholmNCT05810311Written as Roxadustat
- Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory MDS-RSNot yet recruitingPhase 4Peking Union Medical College HospitalNCT06006949Written as Roxadustat
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingPhase 3Astellas Pharma Global Development, Inc.NCT05970172Written as Roxadustat
- Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic NephropathyCompletedNot applicableHanzla ArshadNCT07786168Written as Roxadustat
- Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease PatientsCompletedPhase 4Alexandria UniversityNCT06115421Written as Roxadustat
- Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney DiseaseCompletedPhase 4Second Xiangya Hospital of Central South UniversityNCT07359027Written as Roxadustat
- Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass GraftingTerminatedPhase 2Peking Union Medical College HospitalNCT05010460Written as Roxadustat
- Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.Active, not recruitingPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT06772272Written as Roxadustat
- Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable DialysisCompletedPhase 3Astellas Pharma Europe B.V.NCT02278341Written as Roxadustat
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin AlfaCompletedPhase 3Astellas Pharma Europe B.V.NCT02021318Written as Roxadustat
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring DialysisCompletedPhase 3Astellas Pharma Europe B.V.NCT01887600Written as Roxadustat
- A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With AnemiaCompletedPhase 3Astellas Pharma IncNCT02988973Written as roxadustat
- A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult SubjectsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT03960489Written as Roxadustat
- A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With AnemiaCompletedPhase 3Astellas Pharma IncNCT02964936Written as roxadustat
- A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) TreatmentCompletedPhase 3Astellas Pharma IncNCT02779764Written as roxadustat
- A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With AnemiaCompletedPhase 3Astellas Pharma IncNCT02952092Written as roxadustat
See all 61 studies that test roxadustat →
Given in every arm · 1 — roxadustat is usual care beside what is tested
As the comparator · 1 — what is tested is compared with roxadustat
Codes
What other systems call roxadustat · ClinicalTrials.gg INT006377
- MeSH (NLM) C584543roxadustatOne source NLM
- UNII (FDA) X3O30D9YMXROXADUSTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27088611roxadustatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C141436RoxadustatOne source FDA
- DrugBank DB04847One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C584543 | roxadustat | One source NLM |
| UNII (FDA) | X3O30D9YMX | ROXADUSTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27088611 | roxadustat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C141436 | Roxadustat | One source FDA |
| DrugBank | DB04847 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.